News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EKR Therapeutics, Inc. Release: New Study Demonstrates Ready-to Use Cardene(R) I.V. More Effective than Labetalol for Immediate Control of Blood Pressure in Emergency Room Patients


9/29/2010 8:08:10 AM

BEDMINSTER, N.J.--(BUSINESS WIRE)--Results from the CLUE study, a head-to-head comparison between Ready-to-Use CardeneĀ® I.V. (nicardipine) and labetalol in the emergency room, showed that Ready-to-Use Cardene I.V. lowers acutely elevated blood pressure more effectively than labetalol. These data were presented today at the annual meeting of the American College of Emergency Physicians (ACEP) in Las Vegas, Nevada.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES